Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 19, Number 5—May 2013

Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007

Deanne Langlois-Klassen, Ambikaipakan Senthilselvan, Linda Chui, Dennis Kunimoto, L. Duncan Saunders, Dick Menzies, and Richard LongComments to Author 
Author affiliations: University of Alberta, Edmonton, Alberta, Canada (D. Langlois-Klassen, A. Senthilselvan, L. Chui, D. Kunimoto, L.D. Saunders, R. Long); Provincial Laboratory for Public Health, Edmonton (L. Chui); McGill University Health Centre, Montreal, Quebec, Canada (D. Menzies); McGill University, Montreal (D. Menzies)

Cite This Article


CME Logo

Medscape, LLC is pleased to provide online continuing medical education (CME) for this journal article, allowing clinicians the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Medscape, LLC designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 70% minimum passing score and complete the evaluation at; (4) view/print certificate.

Release date: April 23, 2013; Expiration date: April 23, 2014

Learning Objectives

Upon completion of this activity, participants will be able to:

•     Describe the epidemiology and previous research of the Beijing strains

•     Distinguish characteristics of pulmonary TB with the Beijing strains in the current study

•     Compare the transmissibility of the Beijing and non-Beijing strains in the current study

•     Analyze factors associated with secondary cases of pulmonary TB in the current study

CME Editor

Karen L. Foster, Technical Writer/Editor, Emerging Infectious Diseases. Disclosure: Karen L. Foster has disclosed no relevant financial relationships.

CME Author

Charles P. Vega, MD, Health Sciences Clinical Professor; Residency Director, Department of Family Medicine, University of California, Irvine. Disclosure: Charles P. Vega, MD, has disclosed no relevant financial relationships.


Disclosures: Deanne Langlois-Klassen, PhD; Ambikaipakan Senthilselvan, PhD; Linda Chui, PhD; Dennis Kunimoto, MD; L. Duncan Saunders, MBBCh, PhD; Dick Menzies, MD; and Richard Long, MD, have disclosed no relevant financial relationships.



Beijing strains are speculated to have a selective advantage over other Mycobacterium tuberculosis strains because of increased transmissibility and virulence. In Alberta, a province of Canada that receives a large number of immigrants, we conducted a population-based study to determine whether Beijing strains were associated with increased transmission leading to disease compared with non-Beijing strains. Beijing strains accounted for 258 (19%) of 1,379 pulmonary tuberculosis cases in 1991–2007; overall, 21% of Beijing cases and 37% of non-Beijing cases were associated with transmission clusters. Beijing index cases had significantly fewer secondary cases within 2 years than did non-Beijing cases, but this difference disappeared after adjustment for demographic characteristics, infectiousness, and M. tuberculosis lineage. In a province that has effective tuberculosis control, transmission of Beijing strains posed no more of a public health threat than did non-Beijing strains.

The Beijing lineage of Mycobacterium tuberculosis (also referred to as the East Asian lineage or lineage 2) is an emerging public health threat (1,2). The Beijing lineage accounts for 13% of M. tuberculosis strains globally (3) and 19%–27% of M. tuberculosis strains in low tuberculosis (TB) incidence immigrant-receiving countries, such as Australia, the United States, and Canada (46). In addition to their recent global dissemination, Beijing lineage strains raise concern because of frequent associations with drug resistance and multidrug-resistant TB in particular (1,68). Reports of Beijing strains that are extensively drug resistant further intensify these concerns (7).

The rapid global expansion of Beijing strains and their frequent (albeit inconsistent) association with large TB outbreaks and younger patients has led to speculation that Beijing strains have a selective advantage over other M. tuberculosis lineages as conferred through increased transmissibility and virulence (1,2,7). This hypothesis is supported by experimental evidence of the increased virulence of Beijing lineage strains relative to other M. tuberculosis strains in vitro and in animal models (9,10). Evidence also suggests that the fitness of some Beijing strains is retained after the acquisition of drug resistance (11). Nevertheless, intragenotypic variation in virulence has been described in the Beijing family (12,13) and, in a review, Coscolla and Gagneux (14) concluded that the current body of evidence is insufficient to support the increased transmissibility of these strains.

Immigration is the main determinant of TB epidemiology in low incidence settings (15,16). Consequently, the importation of potentially more pathogenic strains, such as those in the Beijing family, could have major implications for TB prevention and elimination efforts within immigrant-receiving countries. Surveillance activities that identify the sources and transmission patterns of emerging and/or expanding M. tuberculosis strains will be increasingly vital if TB prevention and care programs are to maintain their effectiveness within the context of dynamic immigration policies and highly mobile populations.

We aimed to investigate the association of Beijing and non-Beijing lineage strains with transmission in a low TB incidence immigrant-receiving province of Canada. In particular, we sought to determine whether the Beijing lineage of M. tuberculosis is a greater public health threat than other strains because of increased transmission leading to disease.


Study Setting and Population

Culture-confirmed pulmonary TB cases (potential transmitters) in the province of Alberta, Canada, during January 1, 1991–June 30, 2007 (i.e., study period) in accordance with the provincial TB registry were eligible for inclusion in this population-based retrospective study (see Transmission Leading to Disease below for additional criteria). These cases represent the pulmonary subset of previously reported cases (6). Ethics approval was received from the University of Alberta Health Research Ethics Board, and analysis of surveillance data did not require informed consent because there was no direct patient contact.

Persons born in Canada or born outside of Canada to Canadian-born parents were considered Canadian-born; all others were foreign-born. The Canadian-born population was not further categorized into Aboriginal and non-Aboriginal groups because only 5 Beijing TB cases occurred among Aboriginal peoples during the study period (6). However, because of the high prevalence of Beijing strains in parts of Southeast and East Asia (1), country of birth was used to group foreign-born persons into those born in the Western Pacific region and those born elsewhere (16).

Case Characteristics

Demographic and clinical data from the TB Registry were combined with data from the Provincial Laboratory for Public Health (Provincial Laboratory). The Provincial Laboratory conducts all mycobacteriology studies in the province in accordance with the Canadian Tuberculosis Standards (17).

Sputum smear status and the presence or absence of lung cavitation on chest radiograph were used as indicators of infectiousness. Baseline sputum smears collected on, or within the week before, the date of diagnosis (the start date of treatment) that had grade 3+ to 4+ scores for acid-fast bacilli were categorized as having high bacillary loads (17). Monoresistant isolates had resistance to a single first-line drug, namely isoniazid, rifampin, pyrazinamide, ethambutol, or streptomycin (17). Resistance to >2 first-line drugs but without isoniazid–rifampin resistance constituted polyresistance, whereas multidrug-resistant TB comprised cases with resistance to at least isoniazid–rifampin.

The Provincial Laboratory completed DNA fingerprinting of prospectively archived isolates with the IS6110 restriction fragment-length polymorphism (RFLP) method, and for isolates with <5 copies of IS6110, spoligotyping was performed as described (18). Isolates were also assigned to an M. tuberculosis lineage at the Provincial Laboratory according to the PCR-based detection of large sequence polymorphisms as described (19,20). Isolates with a deletion of RD105 were classified as Beijing lineage strains and all others as non-Beijing lineage strains.

Transmission Leading to Disease

Of the 1,399 eligible pulmonary TB cases during the study period, 20 (1%) were excluded because either the DNA fingerprint pattern or M. tuberculosis lineage could not be determined. The remaining 1,379 cases were included in an analysis of clustering to provide an indication of overall transmission leading to disease during the study period. A cluster was defined as >2 patients whose case isolates had identical DNA fingerprints.

In addition to overall transmission, recent transmission that led to disease was quantified to account for dissimilarities in the follow-up periods of potential source cases and to minimize the probability of propagated transmission by second and later generation source cases (21). A Kaplan-Meier survival analysis was completed with the 1,379 pulmonary TB cases to determine the cutoff point for the definition of recent transmission (21,22). The Kaplan-Meier probability of an isolate being followed by another isolate with an identical fingerprint pattern during the 16.5-year study period was 0.36; the probability of >2 isolates having identical fingerprint patterns in a 2- and 3-year period was 0.22 and 0.24, respectively (Technical Appendix). Given the similarity in these latter probabilities, the 2-year period was subsequently determined to be the ideal cutoff period because it coincided with the conventional high-risk period for the development of active TB after recent infection (18–24 months) (17).

Using the 2-year cutoff point, we defined an index case as a pulmonary TB case with a DNA fingerprint pattern that had not been assigned to another case within the preceding 2 years. A secondary case was any case that had an identical fingerprint pattern as an index case provided that it was also diagnosed no more than 2 years after the index case. Using these definitions, we excluded 430 (31%) of 1,379 TB cases from the analysis of recent transmission. Specifically, 167 index cases diagnosed during 1991–1992 and their 50 secondary cases were excluded because we could not determine whether the fingerprint patterns of the index cases matched another case in the preceding 2 years. Follow-up periods of <2 years resulted in the exclusion of an additional 124 index cases diagnosed after June 2005 and their 10 secondary cases. Finally, 79 secondary cases were excluded because of diagnosis >2 years after the index case but <2 years after another cluster member. After these exclusions, 949 (69%) cases diagnosed during January 1, 1993–June 30, 2007, were included in the primary analysis of recent transmission.

Statistical Analysis

We analyzed data using Stata/IC 11 (StataCorp LP, College Station, TX, USA). For overall transmission, associations between case characteristics and M. tuberculosis lineage were assessed with bivariate and multivariate logistic regression analyses at a 5% level of significance. Characteristics of case-patients (sex, age at diagnosis, population group, sputum smear status, bacillary load, lung cavitation, drug resistance and clustering) that were p<0.2 in bivariate analyses were eligible for inclusion in the multivariate model. Subgroup analyses were also completed to evaluate intragenotypic associations between clustering and case-patient characteristics by using bivariate and multivariate logistic regression analyses.

For the analyses of recent transmission, transmission indices were calculated as the total number of secondary cases within the cutoff period divided by the total number of index cases (21). The risk factors of index cases that were associated with recent transmission leading to disease (i.e., relative transmission indices) were assessed with bivariate and multivariate Poisson regression by using an offset of 1 for each index case (21). Specifically, associations with sex, age at diagnosis, population group, sputum smear status, bacillary load, lung cavitation, drug resistance, and M. tuberculosis lineage were initially analyzed with bivariate Poisson regression. Multivariate Poisson regression modeling was constructed with purposeful selection and, with the exception of M. tuberculosis lineage, variables that had p<0.20 in bivariate regression were included in the initial multivariate model. As the primary variable of interest in this study, M. tuberculosis lineage was included in all multivariate models regardless of its significance.

For all multivariate regression modeling, the confounding effects of removed variables (p>0.05) were assessed with the percentage rule. We used a collapsibility criterion <15%, and the significance of potential interactions was based on the partial likelihood ratio test (23).

We assessed the influence of the length of the cutoff period on recent transmission with sensitivity analyses using 3- and 5-year cutoff periods. Additional analysis was completed with no cutoff period, the index case for each fingerprint pattern being the isolate in the dataset with the earliest date of diagnosis. We also evaluated the potential effect of including nonpulmonary secondary cases in the analysis of recent transmission. For this latter analysis, all nonpulmonary TB cases registered in Alberta during the study period that had an identical DNA fingerprint as a pulmonary index case were eligible for study inclusion.


We identified Beijing strains in 258 (19%) of the 1,379 pulmonary TB cases in 1991–2007. Compared with non-Beijing cases, Beijing cases occurred among persons of similar sex and age but more often foreign-born (p<0.0001) (Table 1). The infectiousness of Beijing and non-Beijing cases was similar in relation to sputum smear status, bacillary load, and presence/absence of lung cavitation (Table 1). M. tuberculosis lineage and drug resistance were not independently associated (Table 1).

Overall Transmission

Overall, 906 (66%) cases exhibited unique fingerprint patterns (nonclustered cases), and 473 (34%) clustered cases were dispersed among 119 clusters. Of Beijing cases, 203 (79%) were nonclustered, and 55 (21%) were distributed among 22 clusters. Non-Beijing cases accounted for the remaining 703 (63%) nonclustered cases and 418 (37%) clustered cases within 97 clusters. Beijing cases were half as likely as non-Beijing cases to be clustered (p<0.0001), but this difference disappeared after we controlled for demographic characteristics, infectiousness, and drug resistance (p = 0.405) (Table 1).

Intragenotypic analysis showed that the clustering of Beijing cases was not associated with demographic characteristics, infectiousness, or drug resistance (Table 2). In contrast, the likelihood of non-Beijing cases being clustered was significantly less when patients were >64 years of age at diagnosis (vs. <35 years; p<0.0001) or foreign-born (p<0.0001) (Table 2). Although resistance to a single first-line anti-TB drug appeared to be associated with less clustering in bivariate analysis (p = 0.001), it was not associated with clustering independent of sex, age at diagnosis, and population group (p = 0.102) (Table 2).


Thumbnail of Number of clustered and nonclustered cases according to Mycobacterium tuberculosis lineage among foreign-born persons and time since arrival in Alberta, Canada, 1991–2007. A) Beijing cases; B) Non-Beijing cases. Gray bars, nonclustered cases; black bars, clustered cases.

Figure. . . Number of clustered and nonclustered cases according to Mycobacterium tuberculosis lineage among foreign-born persons and time since arrival in Alberta, Canada, 1991–2007. A) Beijing cases; B) Non-Beijing cases. Gray...

In each lineage group, the number of nonclustered TB cases in foreign-born persons was inversely associated with time since arrival, such that 30%–32% of these cases occurred within the first 2 years after arrival (Figure). Clustered cases appeared to follow a similar pattern (Figure), although interpretation was limited by the relatively small number of cases.

Recent Transmission

Cases excluded from the analysis of recent transmission were demographically and clinically similar to included cases (data not shown). On average, an index case resulted in 0.13 secondary cases within 2 years. In unadjusted analysis, the number of secondary cases was higher if the index case-patient was sputum smear positive, had a high bacillary load, or had lung cavitation (Table 3). Conversely, fewer secondary cases were associated with index case-patients who were >64 years of age (vs. <35 years), foreign-born, or infected with Beijing strains. In adjusted analysis, the number of secondary cases was associated with the age, population group, and smear status of the index case-patients (Table 3). Specifically, fewer secondary cases occurred if the index case-patient was >64 years of age (vs. <35 years) or foreign-born whereas an increased number of secondary cases was associated with sputum smear–positive index case-patients (Table 3). The lineage of M. tuberculosis was not independently associated with the number of secondary cases.

In subgroup analyses of foreign-born index case-patients, the number of secondary cases per index case-patient was unrelated to the length of residency in Canada. For example, compared with index case-patients who were <2 years since arrival, the relative transmission indices of those 3–5 years and those >20 years since arrival were 1.1 (95% CI 0.3–4.1) and 1.2 (95% CI 0.4–3.6), respectively. Among persons born in the Western Pacific, no risk factors for the number of secondary cases within 2 years per index case-patient were identified, including age, M. tuberculosis lineage, or time since arrival (Table 4).

Sensitivity analyses demonstrated that longer cutoff periods produced higher transmission indices among Beijing cases and non-Beijing cases (Table 5). Although Beijing index cases had significantly fewer secondary cases than did non-Beijing index cases regardless of the length of the cutoff period, M. tuberculosis lineage was not associated with the number of secondary cases within a 2-, 3-, or 5-year cutoff period after we controlled for demographic characteristics and infectiousness. Beijing index cases had significantly fewer secondary cases than did non-Beijing cases independent of other factors when a cutoff period was not defined (equivalent to overall transmission). Inclusion of nonpulmonary secondary cases also increased the transmission indices of Beijing and non-Beijing strains but had no significant effect on relative transmission indices.


Outbreaks of M. tuberculosis Beijing lineage strains in high and low TB incidence settings have had major public health implications (7,24). Notwithstanding the effect of these outbreaks, we found the transmission of Beijing strains to be similar to that of non-Beijing strains in Alberta, a low TB incidence immigrant-receiving province of Canada. Speculation about the increased transmissibility of Beijing strains also has been refuted in other low incidence immigrant-receiving countries and in The Gambia (8,25). In South Africa, findings about the transmissibility of Beijing strains have been conflicting (2,26). The general absence of evidence to suggest that Beijing strains are inherently more transmissible than other M. tuberculosis lineages is highly informative for TB prevention and care programs, given the propensity for multidrug-resistant TB among persons infected with Beijing strains (68).

M. tuberculosis is transmitted most frequently when persons with TB have positive sputum acid-fast bacilli results, especially positive results with higher semiquantitative grades, and lung cavitation (27,28). Consequently, previous findings that Beijing strains are not typically associated with sputum smear positive or cavitary disease (6,29) accords with reported similarities in the transmission of Beijing and non-Beijing strains. In our study, the infectiousness of Beijing and non-Beijing cases was similar in terms of sputum smear positivity and bacillary load, whereas the likelihood of cavitation was significantly less for Beijing cases.

That Beijing strains have been associated with increased transmission in some settings may reflect geographic variations in virulence phenotypes. In the M. tuberculosis complex, evolutionarily modern lineages (including the Beijing lineage) induce weaker immune responses than do ancient lineages, and this response possibly provides modern lineages with a selective advantage in terms of more rapid disease progression and transmission in the human population (30). An array of virulence phenotypes also have been demonstrated in the more evolutionarily recent subfamily of Beijing strains (i.e., the modern subfamily as characterized by the insertion of IS6110 in the noise transfer function chromosomal region [31]), including differences in the pathogenic characteristics (and potential transmissibility) of closely related strains in the same sublineage (12,13). For example, strains in the modern Beijing subfamily have significant variations in their intracellular growth rates and hence significant differences in tumor necrosis factor-α levels (13). This variation may be of particular relevance because of higher tumor necrosis factor-α levels in the bronchoalveolar lavage fluid of TB patients with large cavities (32).

To better understand the potential implications of virulence phenotypes, it would be of benefit if future population-based investigations in high and low incidence settings discerned between the disease characteristics and transmissibility of different M. tuberculosis subfamilies or sublineages. A post hoc analysis of the IS6110 RFLP profiles of Beijing strains in this study found that 6 (2.3%) were <70% homologous to the profiles of the 19 Beijing reference strains (33) and may therefore represent atypical/ancient Beijing strains (31); these 6 isolates had nonclustered IS6110 RFLP profiles.

In agreement with previous studies (15,18,27), the transmission of M. tuberculosis in our study was lower for older and for foreign-born persons and was unrelated to drug resistance. A deeper exploration into these transmission factors in the current study also demonstrates that these factors are independent of M. tuberculosis lineage, at least within the broad categories of Beijing and non-Beijing lineage strains.

TB incidence among foreign-born persons in immigrant-receiving countries has a characteristic and inverse relationship with increased time since arrival (34). Our findings demonstrate that this characteristic relationship is clearly evident for nonclustered cases that presumably result from the reactivation of latent TB infections acquired before immigration. Clustered Beijing and non-Beijing cases also appear to follow a similar pattern. Despite the occurrence of nearly one quarter of clustered Beijing and non-Beijing cases within the first 2 years after arrival, transmission was not associated with time since arrival, a finding that concurs with a previous study (35). Nevertheless, time since arrival may still have major implications for the interpopulation transmission of M. tuberculosis (35). Collectively, these findings emphasize the need for screening and prevention activities in foreign-born persons as a critical means of reducing the reactivation of latent TB infection as early after arrival as possible (36). It also reinforces the need for high-income countries to increase their funding of efforts to expand TB care in high incidence countries (37).

This study reaffirms that foreign-born persons are not a major source of M. tuberculosis transmission (including Beijing strains) despite their high case rates (15,18,21). Rather, the proportion of nonclustered cases suggests that the reactivation of latent TB infection accounts for 82% of foreign-born case-patients (i.e., 80% and 83% of foreign-born Beijing and non-Beijing case-patients, respectively). The inevitable importation of pathogens, such as Beijing strains, therefore should not be viewed so much as a threat as a challenge. The challenge lies in the host country’s resolve to prevent the reactivation of latent TB infection in recently arrived immigrants and in a larger population of aging immigrants while contending with constantly evolving immigration patterns (34).

The maintenance of a comprehensive provincial TB dataset derived through the amalgamation of TB Registry and mycobacteriology data was crucial for this study and the general evaluation of TB prevention and care in Alberta. The accuracy of strain classification also was enhanced through use of an unambiguous and validated genotyping method (19,20). Because Alberta is 1 of 4 primary immigrant-receiving provinces in Canada that has a similar immigration pattern as 2 of the other 3 (i.e., Ontario and British Columbia), the study results are anticipated to have national relevance. The generalizability of the study results to other low TB incidence immigrant-receiving countries will be influenced by the degree to which their immigration patterns are similar.

Unavoidable sampling limitations will have produced underestimates in clustering (38) and affected the transmission indices (39). Nevertheless, sampling bias was minimized in several ways: use of the provincial TB Registry for case identification; culture confirmation of >85% of TB cases in Alberta; availability of an expansive study period; and inclusion of 99% of eligible culture-confirmed pulmonary TB cases. Although a common practice in transmission studies, excluding nonpulmonary secondary cases could produce underestimates in clustering and transmission indices. However, sensitivity analyses in this study found the effect of this limitation to be minimal, the overall associations with transmission being unaffected by the inclusion of nonpulmonary secondary cases.

The transmission index used in this study, while advantageous for quantifying recent transmission within an expansive study period (21), is subject to the same limitations as other TB transmission indices (39). Overestimates in clustering may have resulted from the common molecular epidemiologic assumption that cases with identical DNA fingerprints were part of a transmission cluster (4,27). Although bias may have been introduced by excluding 31% of cases from the analysis of recent transmission, the effect on the study results probably is minimal because of the similarities of included and excluded cases. Last, the relatively small number of secondary Beijing cases and Beijing cases among Canadian-born persons in this study limited the ability to comprehensively assess the cross-population transmission of Beijing strains and the strain-specific transmission patterns in Canadian-born Aboriginal peoples.

This study demonstrated that Beijing strains are not independently associated with increased clustering or a larger number of secondary cases than non-Beijing strains in a setting with comprehensive and effective TB prevention and care practices (40). Combined with the uncommon transmission of M. tuberculosis by foreign-born persons in this and other studies that led to disease (15,18), there appears to be little cause for concern about the importation and subsequent transmission of Beijing strains in low TB incidence immigrant-receiving settings.

Dr Langlois-Klassen is a postdoctoral fellow in the Department of Medicine’s Tuberculosis Program Evaluation and Research Unit at the University of Alberta, Edmonton. Her research interests include the molecular and conventional epidemiology of TB, with a focus on TB in foreign-born and Aboriginal populations.



Our gratitude is extended to the staff at the Provincial Laboratory for Public Health and to the members of the Tuberculosis Program Evaluation Research Unit, University of Alberta, Edmonton, Alberta, Canada. We also thank J. Manfreda for his valuable review of an earlier version of this manuscript. None of these persons received compensation for these contributions.

This investigation was supported by grants from the Canadian Institutes of Health Research; Health Canada, First Nations and Inuit Health Branch; and the University Hospital Foundation. D.L.-K. was also supported by the CIHR Frederick Banting and Charles Best Canada Graduate Scholarship–Doctoral Award.



  1. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis. 2006;12:73643. DOIPubMedGoogle Scholar
  2. Cowley  D, Govender  D, February  B, Wolfe  M, Steyn  L, Evans  J, Recent and rapid emergence of W-Beijing strains of Mycobacterium tuberculosis in Cape Town, South Africa. Clin Infect Dis. 2008;47:12529. DOIPubMedGoogle Scholar
  3. Brudey  K, Driscoll  JR, Rigouts  L, Prodinger  WM, Gori  A, Al-Hajoj  SA, Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpoIDB4) for classification, population genetics and epidemiology. BMC Microbiol. 2006;6:23. DOIPubMedGoogle Scholar
  4. Gallego  B, Sintchenko  V, Jelfs  P, Coiera  E, Gilbert  GL. Three-year longitudinal study of genotypes of Mycobacterium tuberculosis in a low prevalence population. Pathology. 2010;42:26772. DOIPubMedGoogle Scholar
  5. Kato-Maeda  M, Kim  EY, Flores  L, Jarlsberg  LG, Osmond  D, Hopewell  PC. Differences among sublineages of the East-Asian lineage of Mycobacterium tuberculosis in genotypic clustering. Int J Tuberc Lung Dis. 2010;14:53844.PubMedGoogle Scholar
  6. Langlois-Klassen  D, Kunimoto  D, Saunders  LD, Chui  L, Boffa  J, Menzies  D, A population-based cohort study of Mycobacterium tuberculosis Beijing strains: an emerging public health threat in an immigrant-receiving country? PLoS ONE. 2012;7:e38431. DOIPubMedGoogle Scholar
  7. Devaux  I, Kremer  K, Heersma  H, Van Soolingen  D. Clusters of multidrug-resistant Mycobacterium tuberculosis cases, Europe. Emerg Infect Dis. 2009;15:105260. DOIPubMedGoogle Scholar
  8. Ghebremichael  S, Groenheit  R, Pennhag  A, Koivula  T, Andersson  E, Bruchfeld  J, Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS ONE. 2010;5:e10893. DOIPubMedGoogle Scholar
  9. López  B, Aguilar  D, Orozco  H, Burger  M, Espitia  C, Ritacco  V, A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol. 2003;133:307. DOIPubMedGoogle Scholar
  10. Manca  C, Reed  MB, Freeman  S, Mathema  B, Kreiswirth  B, Barry  CE III, Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun. 2004;72:55114. DOIPubMedGoogle Scholar
  11. Toungoussova  OS, Caugant  DA, Sandven  P, Mariandyshev  AO, Bjune  G. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol. 2004;42:28190. DOIPubMedGoogle Scholar
  12. Aguilar  D, Hanekom  M, Mata  D, Gey van Pittius  NC, van Helden  PD, Warren  RM, Mycobacterium tuberculosis strains with the Beijing genotype demonstrate variability in virulence associated with transmission. Tuberculosis (Edinb). 2010;90:31925. DOIPubMedGoogle Scholar
  13. Theus  S, Eisenach  K, Fomukong  N, Silver  RF, Cave  MD. Beijing family Mycobacterium tuberculosis strains differ in their intracellular growth in THP-1 macrophages. Int J Tuberc Lung Dis. 2007;11:108793.PubMedGoogle Scholar
  14. Coscolla  M, Gagneux  S. Does M. tuberculosis genomic diversity explain disease diversity? Drug Discov Today Dis Mech. 2010;7:e4359. DOIPubMedGoogle Scholar
  15. Borgdorff  MW, Behr  MA, Nagelkerke  NJ, Hopewell  PC, Small  PM. Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis. 2000;4:28794.PubMedGoogle Scholar
  16. World Health Organization. Global tuberculosis control: surveillance, planning, financing: WHO report 2008; 2008 [cited 2011 Apr 18].
  17. Public Health Agency of Canada, Canadian Lung Association/Canadian Thoracic Society. Canadian tuberculosis standards. 6th ed. Long R, Ellis E, eds. Ottawa (ON): Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and Government Services Canada; 2007.
  18. Kunimoto  D, Sutherland  K, Wooldrage  K, Fanning  A, Chui  L, Manfreda  J, Transmission characteristics of tuberculosis in the foreign-born and the Canadian-born populations of Alberta, Canada. Int J Tuberc Lung Dis. 2004;8:121320.PubMedGoogle Scholar
  19. Gagneux  S, DeRiemer  K, Van  T, Kato-Maeda  M, de Jong  BC, Narayanan  S, Variable host-pathogen compatibility in Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 2006;103:286973. DOIPubMedGoogle Scholar
  20. Tsolaki  AG, Gagneux  S, Pym  AS, Goguet de la Salmoniere  YO, Kreiswirth  BN, Van Soolingen  D, Genomic deletions classify the Beijing strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol. 2005;43:318591. DOIPubMedGoogle Scholar
  21. Borgdorff  MW, van den Hof  S, Kremer  K, Verhagen  L, Kalisvaart  N, Erkens  C, Progress towards tuberculosis elimination: secular trend, immigration and transmission. Eur Respir J. 2010;36:33947. DOIPubMedGoogle Scholar
  22. Jasmer  RM, Hahn  JA, Small  PM, Daley  CL, Behr  MA, Moss  AR, A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991–1997. Ann Intern Med. 1999;130:9718. DOIPubMedGoogle Scholar
  23. Hosmer  DW, Lemeshow  S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.
  24. Frieden  TR, Sherman  LF, Maw  KL, Fujiwara  PI, Crawford  JT, Nivin  B, A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA. 1996;276:122935. DOIPubMedGoogle Scholar
  25. de Jong  BC, Hill  PC, Aiken  A, Awine  T, Antonio  M, Adetifa  IM, Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis. 2008;198:103743. DOIPubMedGoogle Scholar
  26. Marais  BJ, Hesseling  AC, Schaaf  HS, Gie  RP, Van Helden  PD, Warren  RM. Mycobacterium tuberculosis transmission is not related to household genotype in a setting of high endemicity. J Clin Microbiol. 2009;47:133843. DOIPubMedGoogle Scholar
  27. Nava-Aguilera  E, Andersson  N, Harris  E, Mitchell  S, Hamel  C, Shea  B, Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis. 2009;13:1726.PubMedGoogle Scholar
  28. Lohmann  EM, Koster  BFPJ, le Cessie  S, Kamst-van Agterveld  MP, van Soolingen  D, Arend  SM. Grading of a positive sputum smear and the risk of Mycobacterium tuberculosis transmission. Int J Tuberc Lung Dis. 2012;16:147784. DOIPubMedGoogle Scholar
  29. Borgdorff  MW, van Deutekom  H, de Haas  PE, Kremer  K, van Soolingen  D. Mycobacterium tuberculosis, Beijing genotype strains not associated with radiological presentation of pulmonary tuberculosis. Tuberculosis (Edinb). 2004;84:33740. DOIPubMedGoogle Scholar
  30. Portevin  D, Gagneux  S, Comas  I, Young  D. Human macrophage responses to clinical isolates from the Mycobacterium tuberculosis complex discriminate between ancient and modern lineages. PLoS Pathog. 2011;7:e1001307. DOIPubMedGoogle Scholar
  31. Mokrousov  I, Narvskaya  O, Otten  T, Vyazovaya  A, Limeschenko  E, Steklova  L, Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res Microbiol. 2002;153:62937. DOIPubMedGoogle Scholar
  32. Tsao  TCY, Hong  J, Li  LF, Hsieh  MJ, Liao  SK, Chang  KSS. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1 beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis. Chest. 2000;117:1039. DOIPubMedGoogle Scholar
  33. Kremer  K, Glynn  JR, Lillebaek  T, Niemann  S, Kurepina  NE, Kreiswirth  BN, Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol. 2004;42:40409. DOIPubMedGoogle Scholar
  34. Langlois-Klassen  D, Wooldrage  K, Manfreda  J, Sutherland  K, Ellis  E, Phypers  M, Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. Eur Respir J. 2011;38:895902. DOIPubMedGoogle Scholar
  35. Vanhomwegen  J, Kwara  A, Martin  M, Gillani  FS, Fontanet  A, Mutungi  P, Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island. J Clin Microbiol. 2011;49:83444. DOIPubMedGoogle Scholar
  36. Smieja  MJ, Marchetti  CA, Cook  DJ, Smaill  FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst Rev. 2000; (2):CD001363.PubMedGoogle Scholar
  37. Schwartzman  K, Oxlade  O, Barr  RG, Grimard  F, Acosta  I, Baez  J, Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Med. 2005;353:100820. DOIPubMedGoogle Scholar
  38. Glynn  JR, Bauer  J, de Boer  AS, Borgdorff  MW, Fine  PE, Godfrey-Faussett  P, European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 1999;3:105560.PubMedGoogle Scholar
  39. Tanaka  MM, Phong  R, Francis  AR. An evaluation of indices for quantifying tuberculosis transmission using genotypes of pathogen isolates. BMC Infect Dis. 2006;6:92. DOIPubMedGoogle Scholar
  40. Jensen  M, Lau  A, Langlois-Klassen  D, Boffa  J, Manfreda  J, Long  R. A population-based study of tuberculosis epidemiology and innovative service delivery in Canada. Int J Tuberc Lung Dis. 2012;16:439. DOIPubMedGoogle Scholar




Follow Up

Earning CME Credit

To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 70% passing score) and earn continuing medical education (CME) credit, please go to Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers. You must be a registered user on If you are not registered on, please click on the New Users: Free Registration link on the left hand side of the website to register. Only one answer is correct for each question. Once you successfully answer all post-test questions you will be able to view and/or print your certificate. For questions regarding the content of this activity, contact the accredited provider, For technical assistance, contact American Medical Association’s Physician’s Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please refer to The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits™. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the certificate and present it to your national medical association for review.

Article Title:
Transmission of Mycobacterium tuberculosis Beijing Strains,
Alberta, Canada, 1991–2007

CME Questions

1. You are seeing family of 5 who emigrated from China one year ago. The father of the family was recently diagnosed with pulmonary tuberculosis (TB), and you are worried about the potential spread of the infection, particularly with virulent strains of Mycobacterium tuberculosis. What should you consider in general regarding the epidemiology of the Beijing lineage of M. tuberculosis?

A.        It accounts for 13% of all TB strains globally

B.        It accounts for less than 2% of cases of TB in immigrant-receiving countries with low rates of infection

C.        It is rarely resistant to treatment

D.        The Beijing strain is less virulent compared with other TB strains in animal models

2.         Which of the following characteristics was most associated with TB infection with the Beijing strains in the current study?

A.        Higher proportion of foreign-born patients

B.        Younger age

C.        More likely to have a positive sputum smear

D.        Higher rates of drug resistance

3.         What should you consider regarding the transmission of Beijing vs non-Beijing strains of TB in the current study?

A.        The Beijing strains were associated with higher rates of clustered cases

B.        The Beijing strains were associated with similar rates of clustered cases compared with non-Beijing strains

C.        The Beijing cases were only more likely to be clustered among foreign-born patients

D.        The Beijing cases were only more likely to be clustered among drug-resistant strains

4.         Which of the following factors was most positively associated with a higher rate of secondary cases of TB in the current study?

A.        Beijing lineage

B.        Age over 64 years in the index case

C.        Positive sputum smear in the index case

D.        Foreign-born patient in the index case

Activity Evaluation

1. The activity supported the learning objectives.

Strongly Disagree

Strongly Agree






2. The material was organized clearly for learning to occur.

Strongly Disagree

Strongly Agree






3. The content learned from this activity will impact my practice.

Strongly Disagree

Strongly Agree






4. The activity was presented objectively and free of commercial bias.

Strongly Disagree

Strongly Agree







Cite This Article

DOI: 10.3201/eid1905.121578

Related Links

Table of Contents – Volume 19, Number 5—May 2013

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Richard Long, 8325 Aberhart Centre, 11402 University Ave NW, Edmonton, AB T6G 2J3, Canada

Send To

10000 character(s) remaining.


Page created: April 25, 2013
Page updated: April 25, 2013
Page reviewed: April 25, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.